Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, SanBio Co's Enterprise Value is 円65,012.45 Mil.
SanBio Co's EBIT for the trailing twelve months (TTM) ended in Jan. 2026 was 円-3,282.71 Mil. Therefore, SanBio Co's EV-to-EBIT ratio for today is -19.80.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, SanBio Co's Enterprise Value is 円65,012.45 Mil.
SanBio Co's EBITDA for the trailing twelve months (TTM) ended in Jan. 2026 was 円-3,274.66 Mil. Therefore, SanBio Co's EV-to-EBITDA ratio for today is -19.85.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, SanBio Co's Enterprise Value is 円65,012.45 Mil.
SanBio Co's Revenue for the trailing twelve months (TTM) ended in Jan. 2026 was 円0.00 Mil. Therefore, SanBio Co's EV-to-Revenue ratio for today is .
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, SanBio Co's Enterprise Value is 円65,012.45 Mil.
SanBio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2026 was 円0.00 Mil. Therefore, SanBio Co's EV-to-FCF ratio for today is .
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
SanBio Co (TSE:4592) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
SanBio Co's current Enterprise Value is 円65,012.45 Mil.
SanBio Co's EBIT for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-3,282.71 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
SanBio Co's current Enterprise Value is 円65,012.45 Mil.
SanBio Co's EBITDA for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-3,274.66 Mil.
SanBio Co's current Enterprise Value is 円65,012.45 Mil.
SanBio Co's Revenue for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.
SanBio Co's current Enterprise Value is 円65,012.45 Mil.
SanBio Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.
SanBio Co's current Enterprise Value is 円65,012.45 Mil.
SanBio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SanBio Co Enterprise Value Related Terms
SanBio Co Enterprise Value Historical Data
* Premium members only.
The historical data trend for SanBio Co's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4592 vs VRTX, REGN, ALNY: Enterprise Value Comparison
For the Biotechnology subindustry, SanBio Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SanBio Co Enterprise Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, SanBio Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where SanBio Co's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
SanBio Co's Enterprise Value for the fiscal year that ended in Jan. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of 円65,012.45 Mil mean?
SanBio Co (TSE:4592) has a Enterprise Value of 円65,012.45 Mil as of Jul. 09, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on SanBio Co and its competitors.
Is SanBio Co's Enterprise Value too high?
SanBio Co's current Enterprise Value is 円65,012.45 Mil. Overall, SanBio Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does SanBio Co's Enterprise Value compare to VRTX and REGN?
SanBio Co's Enterprise Value of 円65,012.45 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on SanBio Co and its competitors. SanBio Co's current Enterprise Value is 円65,012.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SanBio Co stock overvalued right now?
SanBio Co (TSE:4592) has a current Enterprise Value of 円65,012.45 Mil. The current Enterprise Value is 円65,012.45 Mil. SanBio Co's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For SanBio Co (TSE:4592), the current Enterprise Value is 円65,012.45 Mil as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.
22GF Score
Get the complete analysis for TSE:4592
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4592 has been successfully added to your 
